Pharmaguy's Insights Into Drug Industry News
184.5K views | +6 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

Does Boehringer Ingelheim Have “The Balls” Needed to Compete?

Does Boehringer Ingelheim Have “The Balls” Needed to Compete? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

When Boehringer Ingelheim had the chance to snatch a prize biotech company from under a rival’s nose a few years back, it decided to pass. That 2011 decision didn’t sit well with some members of the family that controls the 132-year-old German drugmaker.

 

“We didn’t have the balls to acquire something like this,” Mathias Albert Boehringer groused to his second cousin, Christoph Boehringer, via text message. “I expected as much.”

 

The exchange, disclosed this year in court testimony, exemplifies the stresses facing Boehringer Ingelheim. With a younger, more ambitious generation in charge now, it’s set an internal goal of boosting sales by almost 60 percent by 2025, to 25 billion euros ($28.5 billion). Currently, that would rank it among the world’s top 10 drugmakers. Still, the company remains secretive and reluctant to take bold steps.

 

The family’s attitude limits Boehringer Ingelheim’s ability to take risks as it tries to compete with pharma giants such as Merck & Co. and Bristol-Myers Squibb Co. in the high-stakes and costly business of developing new drugs for illnesses such as cancer, obesity-linked liver disease or Alzheimer’s. The company has repeatedly ruled out selling shares in an initial public offering, closing off one avenue that would allow it to make bigger bets.

 

“The whole dynamic is much more controlled and less rock-and-roll than a publicly listed firm,” said Ludo Van der Heyden, a professor at INSEAD, the French business school.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Boehringer Ingelheim on Facebook Features PhRMA's Go Boldly Video

Boehringer Ingelheim on Facebook Features PhRMA's Go Boldly Video | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Boehringer Ingelheim, Ridgefield, Connecticut. 274,934 likes · 104 talking about this. Official US Facebook channel for Boehringer Ingelheim.

 

Further Reading:

  • “PhRMA's Dark Inspirational Video Starts a 6-Month Offensive: ‘Less Hoodies, More White Coats’”; http://sco.lt/4xLMLR
more...
No comment yet.